“Time-to-Efficacy Outcomes by Observed Abrocitinib Dosing Patterns Among Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE REAL” (2026) SKIN The Journal of Cutaneous Medicine, 10(3), p. s777. doi:10.25251/g9yw0x36.